Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease

Archives of Surgery

Volumn 134, Issue 7, 1999, Pages 722-726

  Öberg, Stefan ^a   Peters, Jeffrey H ^b,c   Nigro, John J ^b   Theisen, Jörg ^b   Hagen, Jeffrey A ^b   DeMeester, Steven R ^b   Bremner, Cedric G ^b   DeMeester, Tom R ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM DETECTION; BARRETT ESOPHAGUS; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS MANOMETRY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0032977882     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.7.722     Document Type: Article

References (38)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-1315.
2. El-Serag HB, Sonnenberg A. Opposing time trends of peptic and reflux [abstract]. Gastroenterology. 1997;112:A113.
3. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer. 1988;41:184-197.
4. Blaser MJ. Helicobacter pylori infection and adenocarcinoma of the distal stomach. Eur J Gastroenterol Hepatol. 1993;5(suppl 1):S99-S102.
5. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287-1289.
6. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510-513.
7. Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci. 1997;42:103-105.
8. Csendes A, Smok G, Cerda G, Burdiles P, Mazza D, Csendes P. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus. Dis Esophagus. 1997;10:38-42.
9. Varanasi RV, Fantry GT, Wilson KT. Protective role of Helicobacter pylori infection in gastroesophageal reflux disease [abstract]. Gastroenterology. 1998;114: A322.
10. Subei IM, Salama M, Elderiny S, O'Brien MJ. Does Helicobacter pylori play a role in gastroesophageal reflux disease (GERD) [abstract]? Gastrointest Endosc. 1998; 47:AB76.
11. → strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res, 1998;58:588-590.
12. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 1998;115:50-57.
13. Weston AP, Badr AS, Topalosvki M, Cherian R, Dixon A. Prospective evaluation of the association of gastric H pylori infection with Barrett's dysplasia and Barrett's adenocarcinoma [abstract]. Gastroenterology. 1998;114:A703.
14. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenlerology. 1997;112:1442-1447.
15. Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol. 1992;87:1102-1111.
16. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease Gastroenterology. 1995;109:681-691.
17. Carbone F, Neri M, Laterza F, Ricciuti M, Sajterova Z, Cuccurullo F. Twenty-four hour esophageal pH-metry in patients with non-ulcer dyspepsia is unchanged after H pylori eradication [asbtract]. Gastroenterology. 1998;114:A84.
18. Talley NJ, Janssens J, Lauritsen K, et al. No increase of reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication: a randomized double blind placebo-controlled trial [abstract]. Gastroenterology. 1998;114:A306.
19. O'Connor HJ, McGee C, Mehana N, Cunnane K. Prevalence of gastroesophageal reflux disease (GERD) in H pylori-positive peptic ulcer disease and the impact of eradication therapy [asbtract]. Gastroenterology. 1998;114:A244.
20. Peterson WL, Bamett CC, Evans DJJ, et al. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol. 1993;88:2038-2043.
21. Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 1989;1:1167-1168.
22. + Helicobacter pylori strains. J Clin Microbiol. 1995;33:1496-1500.
23. Spechler SJ, Wang HH, Chen YY, Zeroogian JM, Antonioli DA, Goyal RK. GERD versus H pylori infections as potential causes of inflammation in the gastric cardia [abstract]. Gastroenterology. 1997;112:A297.
24. Öberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg. 1997;226:522-530.
25. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet. 1994;344:1533-1536.
26. Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol. 1997;92:414-418.
27. Spechler SJ, Wang HH, Chen YY, Zeroogian JM, Antonioli DA, Goyal RK. Inflammation of the cardia and H pylori infections are not risk factors for intestinal metaplasia at the esophagogastric junction. Gastroenterology. 1997;112:A297.
28. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H pylori infection. Gastroenterology. 1998;114:633-639.
29. Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalovski M. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus. Dig Dis Sci. 1997;42:597-602.
30. Morales TG, Bhattacharyya A, Johnson C, Sampliner RE. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia? Am J Gastroenterol. 1997;92:1818-1822.
31. Jain R, Aquino D, Hartord WV, Lee E, Spechler SJ. Cardiac epithelium is found infrequently in the gastric cardia [abstract]. Gastroenterology. 1998;114:A160.
32. Bowrey DJ, Clark GWB, Stockdale E, Williams GT, Carey PD. Histological abnormalities at the gastro-esophageal junction: correlation with acid and bile reflux [abstract]. Gastroenterology. 1998;114:A79.
33. Van Vaerenbergh W, Tack J, Geboes K, et al. Microscopic Barrett's esophagus: relationship to acid and bile reflux in man [abstract]. Gastroenterology. 1998; 114:A322.
34. Haggitt RC. Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol. 1992;23:475-476.
35. Price AB, Levi J, Dolby JM, et al. Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut. 1985; 26:1183-1188.
36. Sipponen P. Helicobacter pylori infection: a common worldwide environmental risk factor for gastric cancer? Endoscopy. 1992;24:424-427.
37. De KE, Buset M, Fernandes E, Deltenre M. Helicobacter pylori: the link with gastric cancer. Eur J Cancer Prev. 1994;3:247-257.
38. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process -First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-6740.